Westman Peter C, Lipinski Michael J
MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington DC, USA.
J Thorac Dis. 2015 Oct;7(10):1687-90. doi: 10.3978/j.issn.2072-1439.2015.10.47.
The use of statins to treat patients with heart failure (HF) is controversial due to conflicting results from large, prospective, randomized, placebo-controlled trials and other smaller studies. A recent comprehensive, well-conducted meta-analysis from Preiss and colleagues sought to determine whether statin therapy had an effect on major HF outcomes such as hospitalization and death. Although the study demonstrated a significant effect of statin therapy on HF hospitalizations, several limitations involving the participant data and nature of statin used in the analyzed trials raise questions about the inferences that can be drawn from the study results.
由于大型前瞻性随机安慰剂对照试验及其他较小规模研究结果相互矛盾,使用他汀类药物治疗心力衰竭(HF)患者存在争议。普赖斯及其同事近期进行了一项全面且实施良好的荟萃分析,旨在确定他汀类药物治疗是否对诸如住院和死亡等主要心力衰竭结局有影响。尽管该研究表明他汀类药物治疗对心力衰竭住院有显著影响,但分析试验中涉及参与者数据及所用他汀类药物性质的若干局限性,引发了对能否从研究结果得出的推论的质疑。